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ABSTRACT
We examined whether the human nucleotide excision
repair complex, which is specialized on the removal
ofbulkyDNAadducts,alsodisplaysacorrectingactiv-
ity on base mismatches. The cytosine/cytosine (C/C)
lesion was used as a model substrate to monitor the
correction of base mismatches in human cells.
Fibroblasts with different repair capabilities were
transfected with shuttle vectors that contain a site-
directed C/C mismatch in the replication origin,
accompanied by an additional C/C mismatch in one
of the flanking sequences that are not essential for
replication. Analysis of the vector progeny obtained
from these doubly modified substrates revealed that
C/C mismatches were eliminated before DNA syn-
thesis not only in the repair-proficient background,
but also when the target cells carried a genetic defect
in long-patch mismatch repair, in nucleotide excision
repair, or when both pathways were deleted. Fur-
thermore, cells deficient for long-patch mismatch
repair as well as a cell line that combines mismatch
and nucleotide excision repair defects were able to
correct multiple C/C mispairs, placed at distances
of 21–44 nt, in an independent manner, such that
the removal of each lesion led to individual repair
patches. These results support the existence of a con-
current short-patch mechanism that rectifies C/C
mismatches.
INTRODUCTION
Spontaneous DNA replication errors arising in both prokar-
yotic and eukaryotic cells are mainly processed by the long-
patch mismatch repair (MMR) system (1–4). This highly
conserved excision repair pathway for the correction of
base mismatches, nucleotide insertions or deletions is able
to distinguish between the parental template DNA and the
newly synthesized daughter strands through its coupling to
the replication machinery (5). Excision repair is directed to
the newly synthesized strand in order to prevent the conversion
of replication errors to irreversible mutations. The human
long-patch MMR complex recognizes base mismatches and
insertion/deletion loops using the dimeric complexes of
hMSH2-hMSH6 (hMutSa) or hMSH2-hMSH3 (hMutSb),
which are homologs of the bacterial MutS protein (6,7). At
least two homologs of bacterial MutL, acting as a hMLH1-
hPMS2 dimer (hMutLa), are required for progression of the
long-patch MMR pathway towards its exonucleolytic step (8).
Eventually, a long stretch (up to 1000 bases) of the newly
synthesized strand including the mispaired or unpaired site
is degraded and DNA is re-synthesized by replicative DNA
polymerases (9,10). Heterozygous germ line mutations in one
of these human MutS or MutL homologs are associated with
the hereditary non-polyposis colorectal cancer (HNPCC) syn-
drome. HNPCC is characterized by the early development of
tumors in the colon, as well as in the endometrium, stomach,
small intestine and ovaries. Patients affected by HNPCC have
usually inherited one defective allele and one wild-type allele
of a MutS or MutL homolog. Functional inactivation of the
latter allele results in long-patch MMR deficiency, which gen-
erates tumor cells with a strong mutator phenotype and
elevated microsatellite instability (11–14).
Alternative MMR activities, which are independent of DNA
replication, have been described in several instances. A prom-
inent case is provided by thymine in G/T mismatches, result-
ing from spontaneous deamination of 50-methylcytosine. This
faulty base is excised by thymine DNA glycosylase (TDG),
thereby initiating a base excision repair mechanism that
restores the correct G/C pair (15,16). Another short-patch
MMR pathway has been found to process base mismatches
generated in recombination intermediates (17). Subsequent
studies showed that several nucleotide excision repair
(NER) factors, including the homologs of the human genes
XPA, XPC, XPF, ERCC 1 and XPG, are components of this
short-patch MMR pathway in meiotic Schizosaccharomyces
pombe cells (18–21). More recently, a short-patch MMR
activity has been described in both meiotic and mitotic stages of
Saccharomyces cerevisiae (22). Finally, a short-patch MMR
activity that removes A/C mispairs has been detected in
extracts of mouse fibroblasts (23). However, these alternative
MMR activities of S.cerevisiae and mouse cell extracts seem
to operate in the absence of NER factors (22,23).
The question of whether there is a DNA replication-
independent MMR mechanism in humans is of primary interest.
In fact, such a process could interfere with the maintenance of
genome stability by eliminating small heterologies between
recombining DNA sequences. When hybrid DNA is formed as
part of the recombinational process, mispaired bases arise at
*To whom correspondence should be addressed. Tel: +41 1 635 8763; Fax: +41 1 635 8910; Email: naegelih@vetpharm.unizh.ch
Nucleic Acids Research, Vol. 32 No. 22 ª Oxford University Press 2004; all rights reserved
6696–6705 Nucleic Acids Research, 2004, Vol. 32, No. 22
doi:10.1093/nar/gkh990
 Published online December 21, 2004
sites of sequence divergence between two homologous
chromosomes. The resolution of mismatched heteroduplex
DNA in meiotic recombination intermediates is thought to
account for gene conversion effects (17,22). Furthermore,
the removal of sequence dissimilarities during mitotic recom-
bination processes constitutes an important determinant for
the loss of heterozygosity during tumor development. Previous
reports indicate that the C/C mismatch represents a structurally
unique type of mispair because it induces more helix desta-
bilization than other sequence heterologies (24), but without
being a substrate for long-patch MMR activity in Escherichia
coli and yeast (25,26). These findings prompted us to use the
C/C mismatch as a model lesion to search for alternative
MMR reactions, which are not coupled to DNA replication
in human cells.
MATERIALS AND METHODS
In vitro NER assay
Internally labeled 32P-DNA fragments of 147 bp containing
site-directed mismatches, AAF or pivaloyl adducts, were con-
structed by ligation of six oligonucleotides with partially over-
lapping sequences as described previously (27–29). Excision
assays were performed by incubating 50 mg of HeLa whole
cell extract (30) with 147mer DNA substrates (0.5 ng; 75 000
d.p.m.) at 30C for 40 min. The resulting excision products
were resolved on 10% polyacrylamide denaturing gels and
visualized by autoradiography. Radiolabeled 19mer and
30mer oligonucleotides were used as size markers.
In vitro MMR assay
The MMR efficiency of cell extracts (50 mg) was tested by
incubation with 5 ng of bacteriophage 13mp2 DNA hetero-
duplex containing a mismatch in the lacZ a-complementation
gene (31,32). The repaired DNA was purified and subse-
quently introduced by electroporation into E.coli NR9162
(a mutS strain), which was plated on to a minimal medium
in a soft agar layer containing CSH50 (the a-complementation
strain), 0.5 mg of isopropyl-b-D-thiogalactopyranoside and
2 mg of 5-bromo-4-chloro-3-indoyl-b-D-galactopyranoside.
After 20 h at 37C, the plaques were counted and classified
as blue, colorless or mixed. Repair efficiency (%) was
calculated as follows: 100 · [1  (% mixed plaques in
extract-treated sample)/(% mixed plaques in mock sample
without extract)]. Recombinant hMutLa dimer was expressed
in Spodoptera frugiperda cells (33).
Construction of pS189 derivatives
The single-stranded form of pS189 was prepared using the
helper phage R408. Site-specific modifications were intro-
duced into covalently closed pS189 DNA by annealing and
extending mutagenic primers (34). The sequence of each phos-
phorylated oligonucleotide is shown in Table 1. Oligonucleo-
tides P1 and P2 were used to synthesize the unmodified control
substrate. P3 and P4 were used for the construction of substrate
1, P3 and P5 for substrate 2, P6 and P7 for substrate 3, P8 and
P9 for substrate 4, P9 and P10 for substrate 5, and P5 and P11
for substrate 6. The primers were annealed in a 10-fold molar
excess to 40 mg (0.1 mg/ml) single-stranded pS189 DNA (in
50 mM NaCl, 10 mm Tris–HCl, 10 mM MgCl2 and 1 mM
dithiothreitol, pH 7.9) by heating to 65C for 8 min, then
cooling slowly to 4C. The primer extension and ligation
reactions were performed with 35 U of T4 DNA polymerase
(Roche) and 70 U of T4 DNA ligase (New England Biolabs),
following the manufacturer’s instructions. The substrates
were methylated by incubation with dam methylase and
S-adenosylmethionine (New England Biolabs). Closed
circular DNA was then isolated by CsCl density gradient
centrifugation, purified by gel filtration (MicroSpin S-400
HR columns, Amersham Biosciences) and concentrated in a
centrifugal filter device (Microcon YM-30, Millipore).
Host cell reactivation assay
The SV40-transformed human fibroblasts (GM00637,
GM04312C, GM08437 and GM14931) were purchased
from the Coriell Institute for Medical Research (Camden,
NJ). The 293T human embryonic kidney cell line was a
gift from Dr K. Ballmer, and the XP12RO and XP12ROB4
fibroblast cell lines were a gift from Dr P. Karran. The cell
lines were grown in Dulbecco’s modified Eagle’s medium
supplemented with 10% FCS and, prior to each experiment,
seeded into 35-mm wells until the cultures reached 80% con-
fluence. The pS189 vector (0.25 mg DNA per well) was trans-
fected using the Lipofectamine Plus reagent from Invitrogen.
Cells were harvested 48 h later, subjected to alkaline lysis and
progeny plasmids were isolated using QIAprep spin columns
(Qiagen). The DNA was treated with DpnI (New England
Biolabs) to digest the parental strands carrying the bacterial
dam methylation pattern. An aliquot of the DpnI digest was
used to transform competent E.coli DH5a. Transformants
were plated onto Luria–Bertani (LB) agar plates containing
ampicillin (100 mg/ml) and replication efficiency was
Table 1. Oligonucleotide primers used to synthesize the pS189 vector
derivatives
Primer Sequencea
P1 50-CCTCACTACTTCTGGAATAGCTCAGAGGCCGA-
GGCGGCCTCGGCCTCTGC-30
P2 50-GGTTCTTTCCGCCTCAGAAGGTACCTAACCAA-
GTTCCTC-30
P3 50-CCTCACTACTTCTGGAATAGCTCAGAGCCCGA-
GGCGGCCTCGGCCTCTGC-30
P4 50-GGTTCTTTCCGCCTCAGAAGCTACCTAACCAA-
GTTCCTC-30
P5 50-GCAAAAGCCTACGCCTCCAAAAAAGCCTCC-30
P6 50-CCTCACTACTTCTGGAATAGCTCAGAGACCGA-
GGCGGCCTCGGCCTCTGC-30
P7 50-GGTTCTTTCCGCCTCAGAAGATACCTAACCAA-
GTTCCTC-30
P8 50-CCTCACTACTTCTGGAATAGCTCAGAGCCGAG-
GCGGCCTCGGCCTCTGC-30
P9 50-GGTTCTTTCCGCCTCAGAAGTACCTAACCAAG-
TTCCTC-30
P10 50-CCTCACTACTTCTGGAATAGCTCAGAGCTTGC-
CGAGGCGGCCTCGGCCTCTGC-30
P11 50-CCTCACTACTTCTGGAATAGCTCAGAGCCCGA-
GGCGGCCTCGGCCTCTCCTAAATAAAAAAAAT-
TAGTCAGCC-30
aNucleotides that substitute for G and thus result in mismatches are underlined.
P8introducesa1-nucleotidedeletion,P10a3-nucleotide insertionin theSfiIsite.
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determined by counting the number of ampicillin-resistant
colonies obtained from each 35-mm well. A fraction of
colonies were picked, grown in LB medium containing
ampicillin, and the respective plasmids were isolated by QIA-
prep spin columns. The samples were then subjected to
restriction analysis using the indicated enzymes (New England
Biolabs). Sequencing of the clones was performed by
Microsynth (Switzerland).
RESULTS
In vitro assay for human NER activity
An oligonucleotide excision assay performed in HeLa whole
cell extracts was first used to test whether base mismatches are
susceptible to correction by the human NER complex. Site-
specific lesions (mismatches or DNA adducts) were placed in
the BstBI recognition sequence (50-T1T2C3G4A5A6-30) in the
center of 147 bp long substrates. These linear DNA fragments
were constructed to contain a 32P-labeled residue near the site
of modification (27). Repair reactions performed with the site-
directed substrate containing an acetylaminofluorene (AAF)
adduct at position G4 yielded characteristic excision products
that migrated in polyacrylamide gels as an oligomeric ladder
with lengths ranging from 25 to 30 nt (Figure 1, lane 8).
Similarly, a pivaloyl adduct in combination with a T/T mis-
match at the position T2 (28) induced substantial oligonucleo-
tide excision in the cell extract (Figure 1, lane 9). In contrast,
G/A or G/G mismatches (at the position G4), a C/C mismatch
at the position C3, as well as T/T or T/C mismatches at the
position T2 of the BstBI sequence, were unable to elicit any
excision products that could be distinguished from the back-
ground nuclease ladder generated from the homoduplex con-
trol (Figure 1, lanes 1–7). These results suggest that the human
NER system fails to exert a substantial activity towards base
mismatches, including the C/C lesion.
In vitro assay for human long-patch MMR activity
The repair susceptibility of C/C mismatches was further tested
in vitro using extracts from human cells that are either profi-
cient (HeLa) or deficient (293T, LoVo and HCT15) for long-
patch MMR activity. The 293T human embryonic kidney cell
line lacks expression of the hMLH1 gene due to promoter
hypermethylation and, as a consequence, its interaction part-
ner hPMS2 is degraded (35). LoVo and HCT15 cells are
deficient for MSH2 and MSH6, respectively. The different
cell extracts were incubated with bacteriophage heteroduplex
DNA containing a single G/T or C/C mispair and a DNA nick
on the 30 side relative to the mismatch. MMR activity was
evaluated by bacteriophage plaque analysis following trans-
fection of an E.coli mutS strain with the resulting DNA pro-
ducts (32). As expected, cytoplasmic extracts obtained from
HeLa cells were able to rectify a G/T mismatch located in the
coding sequence of the bacteriophage lacZ a-complementa-
tion gene (Figure 2). This activity was also observed in HeLa
whole cell and nuclear extracts, although less efficiently then
in the corresponding cytoplasmic fraction. Presumably, the
reduced efficiency of these extracts is due to nuclear DNA-
binding factors that might compete with MMR proteins
in vitro (31). Importantly, the loss of G/T correcting activity
in the 293T cytoplasmic extract could be complemented by the
addition of recombinant hMutLa protein. However, neither
the long-patch MMR-proficient HeLa cell extracts nor the
MMR-deficient LoVo and HCT15 cell extracts were unable
to process a C/C mispair above the background level detected
in 293T cytoplasmic extract devoid of hMutLa (Figure 2).
Also, biochemical complementation of the 293T cell extract
with hMutLa failed to restore the correction of C/C mispairs.
Identical results were obtained in experiments performed with
bacteriophage DNA substrate containing a 50 nick (data not
shown).
Characterization of doubly mismatched pS189
substrates
The findings obtained from the in vitro assays for NER and
long-patch MMR activity prompted us to monitor the fate of
C/C mismatches in living human cells. For that purpose, we
constructed derivatives of shuttle vector pS189, containing
site-specific C/C mismatches, that were tagged by treatment
with dam methylase and S-adenosylmethionine before trans-
fection. A direct approach, based on the selective amplification
of repair products, was used to discriminate between the
Figure 1. Assay for in vitro human NER activity. Internally 32P-labeled linear
substrates of 147 bp were incubated with HeLa whole cell extract. The substrate
contained various mismatches as indicated (lanes 2–6), a site-specific AAF-dG
adduct (lane 8) or a site-specific pivaloyl backbone adduct (lanes 9) in the
central BstBI sequence. UM, unmodified homoduplex substrate. The gel has
been overexposed to demonstrate the absence of detectable activity in response
to the mismatches.
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progeny of repaired templates from the contaminating DNA
arising from unrepaired templates. In fact, the modified vec-
tors carried a site-directed C/C lesion, termed C/CSfiI, in the
single SfiI restriction sequence of the simian virus 40 (SV40)
origin. The position of C/CSfiI (nucleotide 3578 in the pS189
vector) corresponds to nucleotide 5235 of the SV40 genome,
which is part of the large T antigen binding site in the core
origin (36) and, hence, essential for the initiation of DNA
replication (Figure 3A). Because a mismatch in this location
disrupts the origin function, the SV40-based vector can be
replicated only after removal of the lesion and full restoration
of the wild-type origin sequence.
Additionally, the substrates were constructed to contain
another C/C mismatch outside the core origin sequence at
positions that are not essential for SV40 replication. This
second C/C mismatch was used as an internal reference to
confirm that the modified vectors were indeed repaired
prior to replication. In substrate 1, the second C/C mismatch
(C/CAcc65I) was incorporated at a distance of 303 nt on the 30
side to C/CSfiI, i.e. in the single Acc65I restriction site
(Figure 3B). Substrate 2 contained the second C/C mismatch
at a different position located 44 nt on the 50 side to C/CSfiI,
within a single AvrII site (Figure 3B). Accordingly, the
second mismatch in substrate 2 is referred to as C/CAvrII.
To verify the presence of these mismatches at the expected
positions, each substrate was subjected to digestion by incuba-
tion with the corresponding restriction endonucleases. The
homoduplex control vector, which was constructed by anneal-
ing fully complementary primers to the SfiI and Acc65I
regions, was linearized by SfiI and Acc65I (Figure 3C,
lanes 2 and 3). In contrast, substrate 1 was resistant to SfiI
and Acc65I digestion due to the presence of a C/C mismatch in
both restriction sites (lanes 5 and 6). Similarly, substrate 2 was
resistant to SfiI and AvrII (lanes 10 and 11), whereas the
unmodified substrate was linearized by these restriction
enzymes (lanes 7 and 8).
Repair of C/C mismatches in normal human
fibroblasts
The pS189 substrates containing C/CSfiI and a second C/C
mismatch (either C/CAcc65I or C/CAvrII) were transfected
into SV40-transformed human fibroblasts. Parallel control
experiments were performed by transfection of unmodified
control vectors. Dose dependence experiments with unmodi-
fied vectors demonstrated that the number of progeny colonies
reached a plateau when fibroblast cultures with 80% conflu-
ence (in 35-mm wells) were transfected with DNA, amounts of
0.5 mg or higher (data not shown). Therefore, subsaturating
quantities of substrate (0.25 mg DNA per 35-mm well) were
used to ensure that even a partial loss of origin activity would
result in a measurable reduction of the final colony counts.
After an incubation period of 48 h, the newly synthesized
progeny molecules were extracted and separated from unrep-
licated DNA by treatment with DpnI, which eliminates par-
ental strands carrying the bacterial dam methylation pattern.
After transfection of E.coli with the DpnI-resistant fraction,
the number of progeny was determined by quantification of
bacterial colonies. A direct comparison showed that the mis-
matched substrates 1 and 2 were replicated in human fibro-
blasts as efficiently as the unmodified vector, indicating that
the C/CSfiI lesion in the origin sequence is rapidly repaired.
Four randomly selected colonies resulting from substrate 1
were amplified for restriction analysis. All four clones were
cleaved by SfiI, as expected if replication occurs only after
exact restoration of the origin sequence (Figure 4A). Three of
Figure 2. Excision of mismatches in an in vitro assay for human MMR activity. Heteroduplex bacteriophage substrates, containing a G/T or C/C mismatch, were
incubated with cytoplamic extracts (CE), whole cell extracts (WCE) or nuclear extracts (NE) prepared from different cell lines. MMR efficiency was quantified after
transformation of an E.coli mutS strain with the in vitro repair products. The mock-treated sample resulted from an incubation without cell extract. Complementation
was performed by the addition of hMutLa to 293T cytoplasmic extracts. Lovo and HCT15 are human cell lines deficient for hMSH2 and hMSH6, respectively.
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Figure 3. Vector pS189 derivatives containing two C/C mismatches. (A) Scheme illustrating the location of C/CSfiI (position 3578) in the SV40 origin of pS189.
The pentanucleotide recognition sequences for T antigen binding are indicated by the arrows. (B) Composition of substrates 1 and 2. (C) Restriction analysis of
substrate 1 (lanes 4–6) and substrate 2 (lanes 9–11). The homoduplex vector was prepared by extension and ligation of unmodified primers. Control, no restriction
endonuclease added.
Figure 4. Independent processing of two neighboring C/C mismatches in human fibroblasts. (A) SfiI and Acc65I restriction analysis of clones 1–4 isolated after
transfection of substrate 1 in wild-type fibroblasts. Control, no enzyme added. (B) Schematic view of the two different repair products isolated after transfection of
substrate 1. (C) AvrII restriction analysis of clones number 1–14 isolated after transfection of substrate 2 in wild-type fibroblasts. (D) Scheme of the two different
repair products of substrate 2.
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these four clones (numbers 2, 3 and 4) were sensitive to both
enzymes, SfiI and Acc65I, suggesting that both C/C
mismatches in substrate 1 had been converted into wild-
type C/G bp, as illustrated in the upper panel of Figure 4B.
In principle, these SfiI- and Acc65I-sensitive products could
also be generated by replication of the parental strand carrying
the wild-type sequence without any previous repair action.
However, we found that clone number 1 was sensitive to
SfiI but resistant to Acc65I (Figure 4A), indicating that the
SfiI site was corrected to yield the wild-type sequence, while
the second mismatch resulted in a G to C transversion (lower
panel of Figure 4B). This particular product can be formed if
C/CSfiI is processed but C/CAcc65I is left unrepaired or, alter-
natively, if C/CSfiI and C/CAcc65I are both repaired but with
opposite strand polarity. Thus, the appearance of such SfiI-
sensitive and Acc65I-resistant clones indicates that the C/C
mismatches must have been corrected prior to replication.
As in the experiments with substrate 1, all products gener-
ated by in vivo replication of substrate 2 in normal fibroblasts
were linearized by SfiI (data not shown). Out of 14 clones
investigated, two were resistant to AvrII (Figure 4C, clones
6 and 12), indicating independent processing of the two mis-
matches, which in substrate 2 were separated by only 44 nt
(Figure 4D). The nucleotide sequencing of these two repres-
entative clones confirmed that the SfiI site in the origin was
restored and also proved the predicted G to C transversion
in the AvrII restriction site. In summary, our results show that
C/C mismatches are efficiently repaired in normal human
fibroblasts. Also, the observation that two neighboring sites
(C/CSfiI and C/CAvrII), with an intervening sequence of only
44 nt, can be processed in an independent manner suggests that
the removal of C/C mismatches may involve the synthesis of
rather short repair patches.
Repair of C/C mismatches in the absence of
long-patch MMR
Apart from normal human fibroblasts, the pS189 vector con-
structs were tested in cell lines with different repair defects. To
determine the potential contribution of the long-patch MMR
system to C/C removal, we transfected substrate 1 into MMR-
deficient 293T cells. These cells were still able to replicate the
vectors containing C/CSfiI, but with slightly reduced efficiency
(78% colony yield compared to the unmodified control sub-
strate containing no C/C mismatches). Other pS189 deriva-
tives were constructed to carry, instead of C/C mismatches,
either A/C mismatches (substrate 3) or single nucleotide dele-
tions (substrate 4) in the SfiI and Acc65I restriction sites
(Figure 5A). Substrate 5 contained a 3-nt insertion in the
SfiI sequence. Substrates 3, 4 and 5 were replicated as effi-
ciently as unmodified vectors in normal fibroblasts, but the
yield of progeny (3–26% of the unmodified control) was sig-
nificantly reduced in 293T cells (Figure 5B). These quantit-
ative differences are in agreement with A/C mismatches and
small deletions/insertions being processed primarily by the
long-patch MMR system, and show that inactivation of
long-patch MMR has more severe consequences for the
removal of A/C mismatches and small deletions/insertions
than for the correction of C/C lesions.
Restriction analysis of four randomly selected clones
obtained from the replication of substrate 1 (containing C/C
mismatches) in 293T cells revealed that all four tested progeny
molecules were sensitive to SfiI, but three clones were resist-
ant to Acc65I (Figure 6A). Similarly, all 20 tested clones
resulting from replication of substrate 2 in 293T cells were
SfiI-sensitive (data not shown), but a large proportion (60%) of
this progeny was resistant to AvrII (Figure 6B). Nucleotide
sequencing of representative clones confirmed the restoration
of the SfiI site as well as the predicted G to C transversion in the
Acc65I and AvrII targets. These results support the existence
of an alternative short-patch pathway by which even closely
spaced C/C mismatches can be processed in an independent
manner.
Repair of C/C mismatches in the absence of
NER factors
We took advantage of xeroderma pigmentosum (XP) cell lines
to determine whether the repair of C/C mismatches requires
Figure 5. Processing of different lesions in long-patch MMR-deficient 293T
cells. (A) Scheme of substrate 3 (pS189 containing two neighboring A/C mis-
matches) and substrate 4 (pS189 containing two neighboring single nucleotide
deletions). (B) Relative yield of progeny after transfection of pS189 derivatives,
carrying the indicated lesions, in 293T cells. Colony numbers (mean values of
two independent experiments) are expressed as the percentages of bacterial
colonies obtained after transfection of the same cells with unmodified control
vector.
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NER factors. When substrate 1 was transfected into XP-A
(GM04312C and XP12RO), XP-F (GM08437) or XP-G
(GM14931) human fibroblasts, all cell lines were able to rep-
licate the modified vector with normal efficiency. Four indi-
vidual clones obtained from each transfection were amplified
and subjected to restriction analysis. The sensitivity to SfiI was
reestablished in all cases but the progeny of each cell line
contained 1–2 clones (in a total of four clones analyzed)
that were resistant to Acc65I (Table 2).
It appears from the results obtained so far that C/C mis-
matches are efficiently corrected even in the absence of a
functional long-patch MMR system or in the absence of
NER activity in XP cells. It remained possible, however,
that both pathways are able to process C/C mismaches and
that they can substitute for each other if only one of the two
mechanisms is eliminated. To rule out this scenario, we tested
a cell line (XP12ROB4) that combines a long-patch MMR
deficiency with a mutation that eliminates NER activity.
This particular cell line carries the same XPA defect as
XP12RO but, additionally, fails to express hMSH2 (37). Inter-
estingly, substrate 1 was replicated with normal efficiency
regardless of whether the host fibroblasts carried only the
XPA mutation (XP12RO) or the combined NER and MMR
defect (XP12ROB4). Four individual colonies obtained from
the XP12ROB4 cells were randomly selected for restriction
analysis. All four clones were sensitive to SfiI, but two clones
were resistant to Acc65I, indicating independent repair of the
mismatches located in different sites (Table 2). Similarly, all
20 tested clones resulting from replication of substrate 2 in
XP12ROB4 fibroblasts were SfiI-sensitive, but a considerable
fraction (6 clones) was refractory to digestion by AvrII
(Table 3). Sequencing of this AvrII-resistant progeny con-
firmed full restoration of the SfiI sequence and the presence
of a G to C transversion at the expected position in the AvrII
site. Taken together, these results are consistent with the cor-
rection of C/C mismatches by an alternative MMR system for
which both long-patch MMR and NER factors are dispensable.
Molecular analysis of C/C repair in long-patch
MMR- and NER-deficient cells
In the cell lines that carry a defect in the long-patch MMR
system, we noted that the two closely spaced C/CSfiI and
C/CAvrII lesions were processed independently with a high
frequency. This observation led us to test whether the altern-
ative human system for C/C repair may involve the formation
of short repair patches, as it has been described previously in
yeast (18,22). For that purpose, a new vector derivative
(substrate 6) was designed where C/CSfiI in the SV40 origin
is flanked by two additional C/C mismatches just outside
the large T antigen binding site (Figure 7A). C/CAvrII was
located at a distance of 44 nt on the 50 side, as in substrate
2. In addition, a third lesion (C/C3599) was positioned on the
30 side, 21 nt away from the central C/CSfiI lesion.
Substrate 6 (carrying the three closely spaced C/C mis-
matches) was used to transfect XP12ROB4 cells, in which
long-patch MMR and NER are inactive. All 24 tested clones
resulting from replication of this composite substrate were
SfiI-sensitive, indicating restoration of the correct origin
sequence. Approximately 50% (13 out of 24) of these clones
were not cleaved by AvrII, indicating a G to C transversion in
Figure 6. Repair of C/C mismatches in long-patch MMR-deficient 293T cells. (A) SfiI and Acc65I restriction analysis of clones 1–4 isolated after transfection of
substrate 1 in 293T cells. (B) Restriction analysis by AvrII of clones 1–20 isolated after transfection of substrate 2 in 293T cells.
Table 3. Restriction analysis of random clones obtained from transfection
of substrate 2
Cell line Defect Clones
tested
Sensitive
to SfiI
Resistant
to AvrII
GM00637 Wild-type 14 14 2
293T hMLH1-hPMS2 20 20 12
XP12ROB4 XPA/hMSH2 20 20 6
Table 2. Restriction analysis of random clones obtained after transfection
of substrate 1
Cell line Defect Clones
tested
Sensitive
to SfiI
Resistant
to Acc65I
GM00637 Wild-type 4 4 1
293T hMLH1-hPMS2 4 4 3
GM04312C XPA 4 4 2
XP12RO XPA 4 4 2
GM08437 XPF 4 4 1
GM14931 XPG 4 4 1
XP12ROB4 XPA/hMSH2 4 4 2
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the most 50 site (data not shown). These SfiI-sensitive but
AvrII-resistant clones were sequenced to identify molecules
with a second G to C transversion in the 30 site. Interestingly, 6
out of a total of 13 AvrII-resistant clones analyzed contained
such a G to C conversion at the position 3599, flanking the SfiI
site (Figure 7B). These results indicate that only the central
C/CSfiI was repaired while the flanking C/C mismatches were
left unrepaired or, alternatively, that all three sites were
corrected but with alternating strand polarity. Such an inde-
pendent processing of closely spaced C/C mismatches was
also detected after transfection of substrate 6 in the MutLa-
deficient 293T cells, thus confirming the presence of a
short-patch C/C repair activity.
DISCUSSION
The SV40 derivative of this study was designed to contain a
C/C lesion in the SfiI site of its origin sequence, such that the
repaired DNA molecules were directly amplified by in vivo
replication. Accordingly, in all daughter clones examined the
C/CSfiI lesion was corrected to the wild-type G/C base pair at
position 3578 of the core origin sequence. The repair products
with opposite strand polarity were not detected in our assay,
because a G to C conversion at position 3578, corresponding to
nucleotide 5235 of the SV40 genome, disrupts the origin
activity (36) and, hence, is not compatible with amplification.
To prove that repair of the C/C mismatch indeed occurs
before the first round of DNA replication, an additional C/C
lesion (C/CAcc65I) was introduced at a distance of 303 nt in a
30 region of the pS189 substrate that is not essential for origin
activity. Alternatively, a second control mismatch (C/CAvrII)
was placed at a distance of 44 nt in a 50 region of pS189, which
is again not required for origin function. These additional C/C
mismatches are converted to both the wild-type (G/C) and
mutated (C/G) base pairs in the respective Acc65I or AvrII
restriction sequences. In the case that replication could occur
without prior repair of the C/CSfiI lesion, only the strand car-
rying the wild-type sequence would give rise to daughter DNA
that can be further replicated. This unlikely event should result
in the recovery of progeny vectors that contain an identical
pattern of SfiI and Acc65I (or AvrII) sensitivity. Instead, a
considerable proportion (on the average 50%) of the progeny
was characterized by the restored SfiI sequence and a mutated
Acc65I site, as expected if the C/CSfiI lesion has undergone a
local repair event before replication. Similarly, AvrII-resistant
clones were detected but at variable frequencies depending on
the long-patch MMR proficiency of the host cells (see below).
The efficient correction of C/C mismatches in wild-type
cells is in agreement with the report of Brown and Jiricny
(38), who estimated that the majority of SV40 genomes con-
taining a C/C mismatch were readily repaired in monkey kid-
ney cells. Surprisingly, the correction of C/C mismatches was
only slightly reduced in the hMutLa-deficient background of
293T cells, and no reduction of repair activity was observed in
another long-patch MMR-deficient cell line (XP12ROB4),
lacking MSH2 expression. However, these findings cannot
be taken as an evidence that the long-patch MMR system
exerts no activity on C/C substrates. In fact, the proportion
of progeny vectors, in which the closely spaced C/CSfiI
Figure 7. Short-patch repair of C/C mismatches. (A) Schematic view of substrate 6 containing three closely spaced C/C mismatches. (B) Sequence of a representative
clone isolated after transfection of substrate 6 in MMR- and NER-defective XP12ROB4 fibroblasts. Red arrows indicate the original position of C/C mismatches in
the substrate.
Nucleic Acids Research, 2004, Vol. 32, No. 22 6703
and C/CAvrII were processed independently, was higher in both
long-patch MMR-deficient cells compared with the MMR-
proficient fibroblasts (Tables 2 and 3). Apparently, some of
these adjacent mismatches were processed by long-patch
MMR and hence removed simultaneously with identical strand
polarity. Thus, our results support a partial contribution of
long-patch MMR to the removal of C/C mismatches in
human cells. Such an involvement has already been proposed
by Genschel et al. (39), who reported that the long-patch MMR
system is able to correct C/C lesions in an in vitro assay
performed with human cell extracts. We found that C/C sub-
strates were not processed by long-patch MMR in a similar
in vitro assay (Figure 2). Since different substrates were used in
these studies, distinct flanking of sequence effects may provide
an explanation for the dissenting results. In any case, the
observation that C/C lesions can be corrected in human cells
despite a long-patch MMR-deficient background prompted us
to test whether, like in S.pombe (18), a mechanism involving
NER factors may act as a backup system to remove such
mismatches. However, the repair of C/C lesions remained
unaffected in XP cells of complementation group A, F and
G, indicating that the NER system does not play a prominent
role in the removal of C/C lesions. This finding is in agreement
with the results of an in vitro excision assay, indicating that the
human NER complex exerts only poor activities against base
mismatches (Figure 1). Using a similar excision assay, Huang
et al. (29) found a weak, although detectable, NER activity
mainly in response to mismatches involving purine bases. In
view of the low-intrinsic susceptibility of pyrimidine mis-
matches to the removal by NER activity, we tested whether
human cells, like S.cerevisiae (22), may display a short-patch
MMR mechanism that is independent of NER factors. For this
purpose, we constructed a pS189 derivative that contains three
consecutive C/C mismatches separated by only 21 and 44 nt.
Indeed, a substantial fraction (25%) of repair products
obtained after transfection of MMR- and NER-deficient
XP12ROB4 cells displayed restriction patterns that could be
generated only by completely independent repair events, with
limited patch size, at each of the three mismatched sites. In
principle, the correction of C/C mismatches could be a result
of random endonuclease cleavage, generating single strand
nicks, and subsequent nick translation along the DNA sub-
strate. However, the observation that C/C mismatches are
corrected by a mechanism that involves very short repair
patches argues against such a non-specific reaction and sup-
ports the conclusion that a specialized process is responsible
for recognition and excision of these particular lesions.
The protein factors that are responsible for the short-patch
correction of C/C mismatches in human cells have not yet been
identified. However, other base mismatches are thought to
be removed by DNA glycosylases (16,40). The human homo-
log of bacterial MutY, which excises adenine from A/G, A/8-
oxoG and, less efficiently, from A/C (41), could be responsible
for the correction of A/C heterologies. In fact, two separate
studies provide evidence for an alternative pathway that
repairs A/C mismatches in mammalian cells. Heywood and
Burke (42) used a shuttle vector assay in SV40-transformed
human cells to demonstrate that the removal of A/C mis-
matches involves repair patches shorter than 40 nt. Oda
et al. (23) detected an A/C repair activity with bias towards
the replacement of adenine in long-patch MMR-deficient
mouse cell extracts. To date, a comparable activity of DNA
glycosylases on cytosines has not been demonstrated, but sev-
eral factors have been shown to bind preferentially to C/C and,
with variable efficiencies, to other pyrimidine-containing mis-
matches. Examples of DNA glycosylases that recognize C/C
mismatches include the E.coli MutM and its counterpart
OGG1 in S.cerevisiae (43), as well as S.pombe Mag1 (44)
and its mammalian functional homolog MPG (45). However,
neither MutM nor MPG exert any detectable incision activity
on C/C substrates in vitro (43,45). The observation that MPG
and similar enzymes release intact bases (mainly guanines)
from DNA, on the other hand, prompted Berdal et al. (46) to
postulate that DNA glycosylases may cleave base-sugar bonds
without absolute damage specificity. Possible candidates
for the excision of cytosines include the pyrimidine DNA
glycosylase hNTH1 (47) or one of the recently identified
NEIL glycosylases (48,49).
In the absence of a molecular signal for strand discrimina-
tion, alternative short-patch MMR activities may act in a
mutagenic manner by processing randomly one or the other
partner of mismatched bases. This activity could play a role in
HNPCC cells that are deficient for the main long-patch MMR
system, thereby accelerating the conversion of replication
errors to mutations. Short-patch MMR activities are also likely
to influence the frequency of meiotic and mitotic recombina-
tion events. In fact, it has been shown that long-patch MMR
components are involved in preventing the recombination be-
tween divergent sequences (50). If mismatches formed in
recombination intermediates are eliminated by an MMR-
independent system, the sequences of the pairing DNA mole-
cules become more similar, which increases the probability for
recombination to occur. In pre-carcinogenic cells, where one
copy of a particular tumor suppressor gene is mutated, this
short-patch MMR-mediated mechanism could enhance the
rate by which the heterozygous state is lost.
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